Literature DB >> 10439773

The effects of desflurane on the nervous system: from spinal cord to muscles.

Y Péréon1, J M Bernard, S Nguyen The Tich, R Genet, F Petitfaux, P Guihéneuc.   

Abstract

UNLABELLED: Monitoring of motor pathways via muscle contraction recording is sensitive to anesthetics, particularly volatile anesthetics. However, the specific action sites of these anesthetics on the spinal cord and the peripheral nervous system are not well known in humans. Therefore, we studied proximal and distal motor and sensory nerve conduction, neuromuscular junction transmission, and spinal cord excitability (H/M amplitude ratio and F-wave amplitude and persistency) using standard neurophysiological techniques in 10 patients who underwent orthopedic surgery. Muscle potentials evoked by spinal cord stimulation were recorded in five additional patients. Desflurane was introduced to achieve end-tidal concentration of 3.7% and 7.4%, in 50% O2/N2O and in 100% O2. Measurements were obtained before desflurane administration and 20 min after obtaining a stable level of each concentration. Peripheral nerve conduction and neuromuscular function were not significantly affected by desflurane. However, spinal cord excitability was significantly decreased by desflurane administration (H/M ratio 37% +/- 9%, 12% +/- 5%, 7% +/- 4% at desflurane concentration 0.0%, 3.7%, and 7.4% in 100% O2, respectively). Muscle potentials evoked by spinal cord stimulation were abolished by desflurane. These data rule out the possibility that desflurane specifically alters peripheral nerve conduction or synapse transmission at the neuromuscular junction. They demonstrate that desflurane acts preferentially at the level of the spinal motoneuron. IMPLICATIONS: We used neurophysiological techniques to assess the effects of desflurane on spinal cord conduction and excitability, motor and sensory peripheral nerve conduction, and neuromuscular transmission. Our data demonstrate that desflurane acts preferentially at the level of the spinal motoneuron, providing useful information for neurophysiological monitoring and immobilization during surgery and for minimum alveolar anesthetic concentration definition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10439773     DOI: 10.1097/00000539-199908000-00046

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

1.  Synergistic effect of sevoflurane and isoflurane on inhibition of the adult-type muscle nicotinic acetylcholine receptor by rocuronium.

Authors:  Li Liu; Wei Li; Ke Wei; Jun Cao; Jie Luo; Bin Wang; Su Min
Journal:  J Anesth       Date:  2012-12-13       Impact factor: 2.078

2.  Sevoflurane enhances neuromuscular blockade by increasing the sensitivity of skeletal muscle to neuromuscular blockers.

Authors:  Ling Ye; Yunxia Zuo; Peng Zhang; Pingliang Yang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2015-12-25

3.  Desflurane Preconditioning Protects Against Renal Ischemia-Reperfusion Injury and Inhibits Inflammation and Oxidative Stress in Rats Through Regulating the Nrf2-Keap1-ARE Signaling Pathway.

Authors:  Yan Zheng; Hui Lu; Huiqiong Huang
Journal:  Drug Des Devel Ther       Date:  2020-04-03       Impact factor: 4.162

4.  Anaesthesia for thymectomy: Use of ketamine-dexmedetomidine without muscle relaxant.

Authors:  Shapna Varma; Sriraam Kalingarayar
Journal:  Indian J Anaesth       Date:  2013-05

5.  The neuromuscular effects of rocuronium under sevoflurane-remifentanil or propofol-remifentanil anesthesia: a randomized clinical comparative study in an Asian population.

Authors:  Sangseok Lee; Young Jin Ro; Won Uk Koh; Tomoki Nishiyama; Hong-Seuk Yang
Journal:  BMC Anesthesiol       Date:  2016-08-22       Impact factor: 2.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.